What is DexCom's stock-based comp?

DexCom (DXCM) reported stock-based comp of $43.3M in Q1 2026.

How has DexCom's stock-based comp changed year-over-year?

DexCom's stock-based comp increased by 26.6% year-over-year, from $34.2M to $43.3M.

What is the long-term trend for DexCom's stock-based comp?

Over 4 years (2021 to 2025), DexCom's stock-based comp has grown at a 8.9% compound annual growth rate (CAGR), from $113.4M to $159.6M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

DexCom DXCM Stock-Based Comp

Stock-Based Comp at other companies

Frequency ElectronicsFEIM

$493.5K+70.0%

SOL

SOLSSOLS

$5M-16.7%

Orion Group HoldingsORN

$2.01M+32.1%

Cabot CorporationCBT

$4M-33.3%

HES

Hess MidstreamHESM

$200K-33.3%

Main Street CapitalMAIN

$5.11M+5.4%

Other financials

Income statement

See full

Revenue$1.3B+13.1%

Gross profit$830.0M+20.5%

Operating income$318.3M+49.7%

Net income$249.1M+38.5%

EPS (diluted)$0.64+42.2%

Balance sheet

See full

Cash & equivalents$1.1B-4.8%

Total debt$103.3M-23.1%

Total equity$2.6B+1.9%

Total assets$6.5B-11.9%

Cash flow

See full

Operating cash flow$525.6M+186%

CapEx$76.6M-12.0%

Free cash flow$449.0M+364%

Valuation

See full

Market cap$28.88B-17.0%

Enterprise value$27.88B-17.4%

P/E28.9×-32.0×

P/S5.8×-2.3×

Profitability

See full

Gross margin62.5%+3.7pp

Operating margin22.9%+6.9pp

Net margin20.1%+6.8pp

FCF margin29.7%+15.8pp

Returns & leverage

See full

Return on equity38.5%+15.7pp

Debt / equity0×0.0×

Current ratio1.7×+0.2×

Where this comes from

Reported directly by DexCom in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: DexCom’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DexCom's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is DexCom's stock-based comp?: DexCom (DXCM) reported stock-based comp of $43.3M in Q1 2026.
How has DexCom's stock-based comp changed year-over-year?: DexCom's stock-based comp increased by 26.6% year-over-year, from $34.2M to $43.3M.
What is the long-term trend for DexCom's stock-based comp?: Over 4 years (2021 to 2025), DexCom's stock-based comp has grown at a 8.9% compound annual growth rate (CAGR), from $113.4M to $159.6M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.